Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 55 min ago
Peer-reviewedCC BYJournal of clinical apheresis

Plerixafor and G‐CSF Versus Placebo and G‐CSF in Moderately Mobilizing Patients With Multiple Myeloma to Optimize Hematopoietic Stem Cell Collection Results (OPTIMIZE)

6 more authors
5 affiliations
  1. 1Medical University Vienna
  2. 2Center for Oncology and Hematology, Clinic Ottakring
  3. 3Medical University of Graz
  4. 4Clinic Donaustadt
  5. 5Medical University of Vienna

Related

  1. Stem cell mobilization with G-CSF and on-demand plerixafor in newly diagnosed multiple myeloma patients treated with daratumumab: a single-center experience
    Barbara Skopec, Luka Cemazar, Matevz Skerget
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  2. Risk-tailored antiemetic prophylaxis with NEPA in Chinese cancer patients receiving moderately emetogenic chemotherapy : MyRisk study subgroup analysis
    Yu Cheng, Xin Lu, Wenyong Tu +3
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
  3. Associations between a series of composite glucose-lipid indices and moderately increased albuminuria in patients with type 2 diabetes mellitus: a cross-sectional study
    Yaru Li, Zhenyu Pan, Xinbo Zhao +3
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefEurope PMC
  4. Spatial mapping of loco regional recurrences and disease related outcomes in breast cancer patients with Internal Mammary Node (IMN) positivity at presentation treated with a curative intent using moderately hypo-fractionated radiotherapy
    D. Chowdhury, S. Chatterjee, S. Chakraborty +2
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  5. A randomized controlled trial of a multidisciplinary collaborative fatigue management program for patients undergoing hematopoietic stem cell transplantation: study protocol
    Jianli Zhang, Liya Ren, Liwei Xu +5
    TrialsPeer-reviewedCC BY-NC-ND 4.0OncologyCrossref
BibTeX
@article{nina2026plerixafor,
  title = {{Plerixafor and G‐CSF Versus Placebo and G‐CSF in Moderately Mobilizing Patients With Multiple Myeloma to Optimize Hematopoietic Stem Cell Collection Results (OPTIMIZE)}},
  author = {Worel Nina and Schreder Martin and Tanzmann Andreas and Kurz Martin and Huber‐Kraßnitzer Bianca and Neumeister Peter and Rosskopf Konrad and Sareban Nazanin and Branka Manuela and Kolovratova Vera and Oesterreicher Sophia and Koerbler Beatrix and Kitzweger Elvira and Ruckser Reinhard and Rabitsch Werner and Agis Hermine and Krauth Maria and Greinix Hildegard T.},
  journal = {Journal of clinical apheresis},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13658576},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Plerixafor and G‐CSF Versus Placebo and G‐CSF in Moderately Mobilizing Patients With Multiple Myeloma to Optimize Hematopoietic Stem Cell Collection Results (OPTIMIZE)
AU  - Worel Nina
AU  - Schreder Martin
AU  - Tanzmann Andreas
AU  - Kurz Martin
AU  - Huber‐Kraßnitzer Bianca
AU  - Neumeister Peter
AU  - Rosskopf Konrad
AU  - Sareban Nazanin
AU  - Branka Manuela
AU  - Kolovratova Vera
AU  - Oesterreicher Sophia
AU  - Koerbler Beatrix
AU  - Kitzweger Elvira
AU  - Ruckser Reinhard
AU  - Rabitsch Werner
AU  - Agis Hermine
AU  - Krauth Maria
AU  - Greinix Hildegard T.
PY  - 2026
DA  - 2026/10/01
JO  - Journal of clinical apheresis
UR  - https://europepmc.org/article/PMC/PMC13658576
SN  - 0733-2459
SN  - 1098-1101
ER  -